Patent · US Active

Detection method for novel ROS1 fusions

US9109259B2 · kind B2 · utility

0Cited by
1References
24Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 22, 2011
Grant dateAug 18, 2015
Priority date
Expiry dateJun 22, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Polynucleotides which are novel causative genes for cancer are elucidated, and a detection method of the polynucleotides or polypeptides encoded by the polynucleotides, and a kit and a primer set for detection are provided, based on the knowledge gained by the elucidation. In the detection method, a fusion gene comprising part of an SDC4, CD74, EZR, SLC34A2, LRIG3, or TPM3 gene and part of a ROS1 gene, or a fusion protein encoded by the fusion gene is detected. The primer set or the detection kit comprises a sense primer designed based on a portion encoding SDC4, CD74, EZR, SLC34A2, LRIG3, or TPM3 and an antisense primer designed based on a portion encoding ROS1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.